Abstract
Background: Warfarin, commonly used anticoagulant in clinic, has serious shortcomings due to its unsatisfactory pharmacodynamics. One of the efficient ways for the improvement of pharmacological and consumer properties of drugs is the development of optimal drug delivery systems.
Objective: The aim of this work is to synthesize novel warfarin – silica composites and to study in vitro the drug release kinetics to obtain the composites with controlled release. Methods: The composites of warfarin with unmodified (UMS) and mercaptopropyl modified silica (MPMS) were synthesized by sol-gel method. The composite formation was confirmed by FTIR spectra. The concentrations of warfarin released to media with pH 1.6, 6.8 and 7.4 were measured using UV spectroscopy. The drug release profiles from the solid composites were described by a series of kinetic models which includes zero order kinetics, first order kinetics, the modified Korsmeyer-Peppas model and Hixson-Crowell model. Results: The synthesized sol-gel composites have different kinetic behavior in the studied media. In contrast to the warfarin composite with unmodified silica, the drug release from the composite with mercaptopropyl modified silica follows zero order kinetics for 24 h irrespective to the release medium pH due to mixed mechanism (duffusion + degradation and/or disintegration of silica matrix). Conclusion: The obtained results showed that warfarin – silica sol-gel composites have a potential application for the development of novel oral formulation of the drug with controlled delivery.Keywords: Pharmacodynamics, release kinetics, release mechanism, silica, sol-gel composite, warfarin.
Graphical Abstract
Current Drug Delivery
Title:Sol-gel Derived Warfarin – Silica Composites for Controlled Drug Release
Volume: 14 Issue: 5
Author(s): Ekaterina S. Dolinina and Elena V. Parfenyuk*
Affiliation:
- Laboratory of Chemistry of Hybrid Nanomaterials and Supramolecular Systems, G.A. Krestov Institute of Solution Chemistry of Russian Academy of Sciences, 1 Akademicheskaya Str., Ivanono, 153045,Russian Federation
Keywords: Pharmacodynamics, release kinetics, release mechanism, silica, sol-gel composite, warfarin.
Abstract: Background: Warfarin, commonly used anticoagulant in clinic, has serious shortcomings due to its unsatisfactory pharmacodynamics. One of the efficient ways for the improvement of pharmacological and consumer properties of drugs is the development of optimal drug delivery systems.
Objective: The aim of this work is to synthesize novel warfarin – silica composites and to study in vitro the drug release kinetics to obtain the composites with controlled release. Methods: The composites of warfarin with unmodified (UMS) and mercaptopropyl modified silica (MPMS) were synthesized by sol-gel method. The composite formation was confirmed by FTIR spectra. The concentrations of warfarin released to media with pH 1.6, 6.8 and 7.4 were measured using UV spectroscopy. The drug release profiles from the solid composites were described by a series of kinetic models which includes zero order kinetics, first order kinetics, the modified Korsmeyer-Peppas model and Hixson-Crowell model. Results: The synthesized sol-gel composites have different kinetic behavior in the studied media. In contrast to the warfarin composite with unmodified silica, the drug release from the composite with mercaptopropyl modified silica follows zero order kinetics for 24 h irrespective to the release medium pH due to mixed mechanism (duffusion + degradation and/or disintegration of silica matrix). Conclusion: The obtained results showed that warfarin – silica sol-gel composites have a potential application for the development of novel oral formulation of the drug with controlled delivery.Export Options
About this article
Cite this article as:
Dolinina S. Ekaterina and Parfenyuk V. Elena*, Sol-gel Derived Warfarin – Silica Composites for Controlled Drug Release, Current Drug Delivery 2017; 14 (5) . https://dx.doi.org/10.2174/1567201813666161021103714
DOI https://dx.doi.org/10.2174/1567201813666161021103714 |
Print ISSN 1567-2018 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5704 |

- Author Guidelines
- Bentham Author Support Services (BASS)
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Colloidal Supramolecular Aggregates for Therapeutic Application in Neuromedicine
Current Medicinal Chemistry The Effect of Statins on Postprandial Lipemia
Current Drug Targets Diagnostic Tools, Biomarkers, and Treatments in Diabetic polyneuropathy and Cardiovascular Autonomic Neuropathy
Current Diabetes Reviews The Medicinal Chemistry of Genus <i>Aralia</i>
Current Topics in Medicinal Chemistry The Therapeutic Role of Xenobiotic Nuclear Receptors Against Metabolic Syndrome
Current Drug Metabolism The Role of Chemokines, Cytokines and Adhesion Molecules in Stem Cell Trafficking and Homing
Current Pharmaceutical Design Remyelination in Multiple Sclerosis: The Therapeutic Potential of Neural and Mesenchymal Stem/Progenitor Cells
Current Signal Transduction Therapy Vitamin D is Related to Markers of Vulnerable Plaque in Acute Myocardial Infarction
Current Vascular Pharmacology Recent Developments in Delivery of Nucleic Acid-Based Antiviral Agents
Current Pharmaceutical Design The Neurophysiology of Hydrogen Sulfide
Inflammation & Allergy - Drug Targets (Discontinued) Molecular Dynamics Simulations of Kv Channels and Gating-Modifier Peptide Toxins
Current Computer-Aided Drug Design Epidemiology and Natural History of Alcoholic Liver Disease
Reviews on Recent Clinical Trials Cell-Based Therapy to Promote Angiogenesis in the Brain Following Ischemic Damage
Current Vascular Pharmacology Oxaliplapin and Capecitabine (XELOX) Based Chemotherapy in the Treatment of Metastatic Colorectal Cancer: The Right Choice in Elderly Patients
Anti-Cancer Agents in Medicinal Chemistry Patent Selections
Recent Patents on Anti-Cancer Drug Discovery CD26/Dipeptidyl Peptidase IV as a Novel Therapeutic Target for Cancer and Immune Disorders
Mini-Reviews in Medicinal Chemistry Mastering the Treatment of Diabetes Mellitus Type 1 in Childhood and Adolescence
Current Pediatric Reviews Nanoparticles as Alternative Strategies for Drug Delivery to the Alzheimer Brain: Electron Microscopy Ultrastructural Analysis
CNS & Neurological Disorders - Drug Targets Patent Annotations
Recent Patents on CNS Drug Discovery (Discontinued) Markers Associated with Sex Differences in Methamphetamine-Induced Striatal Dopamine Neurotoxicity
Current Neuropharmacology